2Tran H, Cheung C, Gill D, et al. Methotrexate-associated man- tle-cell lymphomain an elderly man with myasthenia gravis [J]. Nat Clin Pract Oncol,2008,5 (4) :234-238.
3Agarwal A, Vijay K, Thamburaj K, et al. Transient leukoen- cephalopathy after intrathecal methotrexate mimicking stroke [ J. Emerg Radio1,2011,18 (4) :345-347.
4Summers R J, Abramowsky CR, Cooper TM. Correlating Pa- thology With the Clinical Symptoms of Methotrexate-induced Leukoencephalopathy in a Child With Relapsed T-cell Acute Lymphoblastic Leukemia [ J ]. J Pediatr Hematol Oncol, 2012. [ Epub ahead of print].
5Inaba H, Khan RB, Laningham FH, et al. Clinical and radio- logical characteristics of methotrexate-induced acute encepha- lopathy in pediatric patients with cancer[ J. Ann Oncol,2008, 19(1) :178-184.
6Tufekci O, Yilmaz S, Karapinar TH,et al. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia [ J ]. Pediatr Hematol Oncol, 2011,28 ( 6 ) : 517 -522.
7Cheng KK. Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer[ J. Eur J Cancer Care(Engl) ,2008,17 (3) :306-311.
8Hocaoglu N, Atilla R, Onen F, et al. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy [ J ]. Hum Exp Toxico1,2008,27 (7) :585-589.
9Csordas K, Eipel O, Hegyi M, et al. Pharmacokinetic analysis of high-dose methotrexate treatments in children with hemato- logic malignancies [ J]. Orv Heti1,2011,152 (40) : 1609-1617.
10Barouta G, Karapetsa M, Kostopoulou E, et al. Oral tuberculo- sis in a patient with rheumatoid arthritis after long treatment with methotrexate and adalimumab [ J ]. J Clin Rheumatol, 2010,16(7) :330-331.
